MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64
Detailed results from completed Phase 1b CIMON trial in 21 acute myeloid leukemia (AML) patients treated with the company’s Microbiome Ecosystem TherapyTM (MET) oral capsule, MaaT033, demonstrating its safety and ability to increase gut microbiota richness.Results of the study evaluating the tolerated dose of MaaT03...